牛黄干预缺血性脑卒中的机制与临床应用综述
本文综述牛黄的化学成分及其干预缺血性脑卒中的多成分、多靶点、多通路机制,并汇总含牛黄的中成药与临床安全性信息。牛黄在急性期、亚急性期和恢复期分别发挥神经保护作用,临床与临床前研究证实其安全性。
要点
- 牛黄主要含胆色素、胆汁酸、胆固醇、蛋白质氨基酸和微量元素。
- 牛黄通过多成分、多靶点、多通路干扰脑缺血/再灌注损伤的酶级联反应。
- 含牛黄的中成药用于缺血性脑卒中,临床与临床前研究证实其安全性。
核心结论
- 牛黄治疗缺血性脑卒中有悠久历史、确切疗效和广泛应用。
- 未来应聚焦阐明牛黄的作用机制并探索其应用。
研究设计与样本
- 通过查阅中国古代医籍考察牛黄治疗缺血性脑卒中的历史渊源。
- 分析牛黄的化学成分,并基于Web of Science、PubMed和中国知网等数据库文献总结其抗缺血性脑卒中机制。
- 整合中药制剂与临床报告信息,概述现代应用与安全性考量。
主要发现
- 牛黄主要含胆色素、胆汁酸、胆固醇、蛋白质氨基酸和微量元素等化学成分。
- 牛黄对脑缺血/再灌注损伤的疗效确切,胆色素、胆汁酸和氨基酸等成分可多成分、多靶点、多通路干扰其酶级联反应。
- 急性期牛黄活性成分通过减轻微循环障碍、兴奋性氨基酸毒性和氧化应激损伤发挥神经保护作用。
- 亚急性期牛黄抑制炎症损伤、细胞凋亡和血脑屏障破坏。
- 恢复期牛黄促进血管生成和神经发生。
关键数值与推荐
- 牛黄作为原料药出现在多种治疗缺血性脑卒中的中成药制剂中。
- 临床和临床前研究已证明牛黄的安全性。
临床怎么用
- 牛黄可用于缺血性脑卒中的防治,含牛黄中成药在临床有应用。
- 临床与临床前研究支持牛黄的安全性,但需结合具体制剂和临床情境使用。
局限性
- 未来需进一步阐明牛黄的作用机制并探索其应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bovis Calculus (BC), also named Niuhuang in Chinese, is utilized as a resuscitation drug in Traditional Chinese Medicine (TCM) for the treatment of neurological disorders. Ischemic stroke (IS) is a significant global public health issue that currently lacks safe and effective therapeutic drugs. Ongoing efforts are focused on identifying effective treatment strategies from Traditional, Complementary, and Integrative Medicine. Noticeably, BC has been used in TCM for thousands of years to prevent or treat IS-related diseases. METHODS: The historical origins of BC in the treatment of IS were investigated through the examination of ancient Chinese medical texts. Furthermore, the chemical components of BC were analyzed, and its mechanisms of action against IS were summarized using literature sourced from databases such as Web of Science, PubMed, and China National Knowledge Infrastructure. Information on Chinese medicine preparations and clinical reports was also integrated to provide an overview of modern applications and safety considerations. RESULTS: BC mainly includes chemical components such as bile pigments, bile acids, cholesterol, proteins amino acids, and trace elements. Additionally, the efficacy of BC in treating cerebral ischemia/reperfusion injury (CI/RI) is certain, particularly due to the components of bile pigments, bile acids, and amino acids that can interfere with the enzymatic cascade reaction of CI/RI through multiple components, targets, and pathways. The active components of BC exert neuroprotective effects by reducing microcirculation disturbance, excitatory amino acid toxicity, and oxidative stress injury in the acute stage; inhibiting inflammatory injury, apoptosis, and blood-brain barrier (BBB) disruption in the subacute stage; and promoting angiogenesis and neurogenesis in the restoration stage. Furthermore, as a crude drug, BC appears in many Chinese patent medicine (CPM) preparations for the treatment of IS, and clinical and preclinical studies have proved its safety. CONCLUSION: The use of BC in the treatment of IS has a long history, proven efficacy, and widespread application. Future efforts should focus on elucidating its mechanisms of action and exploring its applications.
引用
- Xu K, Deng B, Jia T, et al. A review of the Bovis Calculus's intervention mechanism and clinical application in ischemic stroke. Front Pharmacol. 2025. PMID: 39881874. doi:10.3389/fphar.2024.1510779
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。